Drugs / Liraglutid
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT03961659 Comparator | May 2019 → Aug 2020 | cognitive impairment with or without cerebellar ataxia, obesity disorder, type 2 diabetes mellitus | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Liraglutid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03961659 ↗ |